MedTrace Logo

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

NCT00093678 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-10-08

No results posted yet for this study

Summary

RATIONALE: Celecoxib may help relieve moderate or severe pain associated with cancer. It may also decrease weight loss and improve muscle strength in cancer patients.

PURPOSE: This randomized clinical trial is studying celecoxib to see how well it works in managing pain, weight loss, and weakness in patients with advanced cancer.

Conditions

Interventions

DRUG

celecoxib

PROCEDURE

anticachectic therapy

PROCEDURE

nutritional support

PROCEDURE

pain therapy

PROCEDURE

supportive care/therapy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Donald P. Lawrence, MD · Tufts Medical Center

  • Michael J. Fisch, MD, MPH, FACP · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00093678 on ClinicalTrials.gov